DrugPatentWatch Database Preview
ASTRAMORPH PF Drug Profile
» See Plans and Pricing
Which patents cover Astramorph Pf, and what generic alternatives are available?
Astramorph Pf is a drug marketed by Fresenius Kabi Usa and is included in four NDAs.
The generic ingredient in ASTRAMORPH PF is morphine sulfate. There are twenty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Astramorph Pf
A generic version of ASTRAMORPH PF was approved as morphine sulfate by HOSPIRA on May 11th, 1988.
Summary for ASTRAMORPH PF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Bulk Api Vendors: | 8 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,138 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ASTRAMORPH PF at DailyMed |
Recent Clinical Trials for ASTRAMORPH PF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute on Drug Abuse (NIDA) | N/A |
| Vanderbilt University Medical Center | N/A |
| National Institutes of Health (NIH) | Phase 4 |
US Patents and Regulatory Information for ASTRAMORPH PF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | ASTRAMORPH PF | morphine sulfate | INJECTABLE;INJECTION | 071050-001 | Oct 7, 1986 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Fresenius Kabi Usa | ASTRAMORPH PF | morphine sulfate | INJECTABLE;INJECTION | 071053-001 | Oct 7, 1986 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Fresenius Kabi Usa | ASTRAMORPH PF | morphine sulfate | INJECTABLE;INJECTION | 071051-001 | Oct 7, 1986 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
